Русский
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic
Avdeev S.N., Chulanov V.P., Alexeeva E.I., Aleshina O.A., Bereznikov A.V., Kotenko O.N., Lila A.M., Mutovina Z.Yu, Parovichnikova E.N., Fomina D.S., Frolova N.F., Shevchenko A.O.
1) Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; 2) National Medical Research Center for Phthisiopulmonology and Infectious Diseases, Moscow, Russia; 3) National Medical Research Center for Children's Health, Moscow, Russia; 4) National Medical Research Center for Hematology, Moscow, Russia; 5) AlfaStrakhovanie-OMS LLC, Moscow, Russia; 6) ROSBIOTECH University, Moscow, Russia; 7) City Clinical Hospital №52, Moscow, Russia; 8) Pirogov Russian National Research Medical University, Moscow, Russia; 9) Nasonova Research Institute of Rheumatology, Moscow, Russia; 10) Russian Medical Academy of Continuous Professional Education, Moscow, Russia; 11) Central State Medical Academy of the Administrative Department of the President of the Russian Federation, Moscow, Russia; 12) Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; 13) Shumakov National Medical Research Center for Transplantology and Artificial Organs, Moscow, Russia
The Chairmen of the Council - Acad. S.N. Avdeev, Prof. V.P. Chulanov
On July 3, 2023, an Interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic realities" with participation of leading experts in the field of pulmonology, rheumatology, hematology, oncology, nephrology, allergology-immunology, transplantology and infectious diseases was held in Moscow. The purpose of the meeting was to discuss the current clinical and epidemiological situation related to COVID-19, the relevance of disease prevention for high-risk patients.
The following questions were discuuses by the experts:
1. Burden of COVID-19 disease in 2023 for immunocompromised patients in various therapeutic areas.
2. Place of passive immunization with monoclonal antibodies as a method of preventing COVID-19 among immunocompromised patients.
3. Necessary conditions for the introduction of passive immunization of immunocompromised patients into routine practice.
DOI: 10.26442/00403660.2023.08.202391
On July 3, 2023, an Interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic realities" with participation of leading experts in the field of pulmonology, rheumatology, hematology, oncology, nephrology, allergology-immunology, transplantology and infectious diseases was held in Moscow. The purpose of the meeting was to discuss the current clinical and epidemiological situation related to COVID-19, the relevance of disease prevention for high-risk patients.
The following questions were discuuses by the experts:
1. Burden of COVID-19 disease in 2023 for immunocompromised patients in various therapeutic areas.
2. Place of passive immunization with monoclonal antibodies as a method of preventing COVID-19 among immunocompromised patients.
3. Necessary conditions for the introduction of passive immunization of immunocompromised patients into routine practice.
DOI: 10.26442/00403660.2023.08.202391
Similar Articles
